Bio-Rad Laboratories, Inc. (BIO)
Sector: Technology
Industry: Laboratory Analytical Instruments
Country: United States
Exchange: NYSE
Other share class: BIO-B
Market cap: $10.27B
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Latest financial period: June 30, 2026
Filed with the SEC: August 4, 2026
Estimated earnings date: November 4, 2026
Profit #1018 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 30.3% | 13.8% | 21.5% | 12.7% |
Growth #1293 of 1484 companies
Payout #737 of 1484 companies
Safety #54 of 1484 companies
Price #1021 of 1484 companies
